Nature 380:435439 Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza RL, Berman DS et al (2003) The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis
Not intended for human or animal consumption, medical use, or therapeutic use
Sermorelin May Be Best For: Adults over 35 experiencing age-related GH decline Those prioritizing sleep quality and recovery Patients new to peptide therapy who want a gentle introduction People seeking long-term anti-aging support Those with a history of sensitivity to hormone therapies CJC-1295 May Be Best For: Adults with specific body composition goals (fat loss, lean muscle preservation) Those who have used sermorelin but want stronger GH stimulation Active individuals focused on workout recovery and performance Patients who prefer less frequent dosing (with DAC version) Those with documented low IGF-1 levels Who Should Not Use These Peptides: Individuals with active cancer or a history of cancer (GH may promote cell proliferation) Patients with uncontrolled diabetes (GH can affect insulin sensitivity) Pregnant or breastfeeding women Those with active pituitary tumors or disorders Individuals under 18 (unless under specialized endocrine care) Can Sermorelin and CJC-1295 Be Used Together
Due to the comparative small size of the rats and large size of the defects, these defects would fairly mimic large fistulas in patients that would hardly heal spontaneously
)
